Our Company
BioGenex designs, develops and commercializes molecular pathology systems for Tumor diagnosis, prognosis, precision medicine and life science research. BioGenex’s industry-leading next-generation cytogenetic FISH workflow solution and miRNA system for characterization of Cancer of Unknown Primary (CUP) and undifferentiated tumors are revolutionizing pathology. Proprietary fully-automated molecular pathology workstations from BioGenex are the most advanced systems available globally. BioGenex prides itself on delivering cutting edge technology, years ahead of the competition, providing the finest systems for immunohistochemistry (IHC), in situ hybridization (ISH), Fluorescence ISH (FISH) and in situ PCR. BioGenex systems and product performance are guaranteed: antibodies, probes, antigen retrieval, detection systems, and histology stains. We provide quality systems and are committed to best in class customer care.
Facts and Figures
| Mission | To become a global molecular medicine company providing affordable solutions for life science research and personalized medicine |
| Founders | Krishan L. Kalra, Ph.D., Satya Kalra |
| CEO | Krishan L. Kalra, Ph.D. |
| Incorporation | San Ramon, California, 1981 |
| Industry | Tissue and cell-based Tumor diagnostics |
| Locations | Headquarters: Fremont, California, USA Regional Center of Excellence: Hyderabad, India Manufacturing Sites: Fremont, California, USA and Hyderabad, India Agency Office: Shanghai, China Wholly Owned Subsidiary in Europe: Milan, Italy Customer Service Centers: Fremont, Hyderabad, Shanghai and Milan |
| Regulatory Certifications | ISO 13485 (2016), ISO 9001 (2015), cGMP, IVD – CE certified |
| Number of Employees | 250+ globally |
| Product Areas | Multiple fully automated molecular pathology workstations Immunohistochemistry (IHC) In-situ hybridization (ISH) Fluorescence in-situ hybridization (FISH) In-situ PCR Multiplex stains MicroRNA and HPV probe system |
| Flagship Products | Xmatrx® systems, i6000™ systems, i500 Plus™, NanoVIP®, Xmatrx® MINI, EZ-Retriever®, IHC primary antibodies, microRNA probes, IHC/ISH detection kits |
| Global Reach | 70+ distributors across 47 countries |
| Customers | Pathologists, histotechnologists, reference labs, clinical lab professionals, pharmaceutical/biotechnology and academic researchers |
| Patents | 25 US and foreign patents granted 28 US and foreign patents pending |
Mission Statement
